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EDITORIAL COMMENTARYHeart and soulAlden H. Harken, MD, FACSSee related article on pages 2373-9.As cardiac surgeons, our primary goal is to make certain
that the body of our patient remains connected to his or
her soul. In their article in this issue of the Journal, Papar-
ella and colleagues1 propose the not-too-surprising hypoth-
esis that increasing perioperative cardiomyocyte damage
increases the likelihood of our patient’s soul departing his
or her body. The image of a completely innocuous myocar-
dial preservation strategy has, like a mirage, haunted car-
diac surgeons for decades.
Paparella and colleagues1 serially measured cardiac
troponin I (cTnI) in 965 patients after mitral and aortic
valve surgery. They found higher cTnI after mitral valve
surgery than after aortic valve surgery, and they concluded
that inclusion of postoperative cTnI in a reference model
that permitted stratification for New York Heart Associa-
tion functional class, left ventricular ejection fraction,
and duration of cardiopulmonary bypass improved the
model’s statistical relationship with postoperative
morbidity and mortality at 3 months. Paparella and col-
leagues1 refer to this increased cTnI as a ‘‘risk’’ and postu-
late that during myocardial revascularization procedures
(such as coronary artery bypass grafting), ‘‘coronary dis-
ease extension, recent myocardial infarction, and incom-
plete revascularization’’ may lead to myocardial damage,
whereas in valve surgery, the efficacy of cardioplegia is
just as likely to be related to cellular necrosis. If indeed
cTnI is elaborated when cardiomyocytes succumb and
spill out this intracellular enzyme, then all cardiac surgery
provokes at least some bump in cTnI when oxygen and
substrate delivery does not meet oxygen and substrate de-
mand. For aortic valve surgery, there is extraordinarily
limited direct incisional damage to the myocardium; in
mitral valve surgery, the atrial incision is unlikely to
release much cTnI. A hypertrophic left ventricle as a result
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2380 The Journal of Thoracic and Cardiovascular Surischemia, and a dilated left ventricle as a result of
mitral insufficiency may also exacerbate the ventricular
‘‘tension,’’ driving up oxygen demand by the rule of Lap-
lace. Thus it seems that analysis of any increase in postop-
erative cTnI must always focus on the adequacy of
cardioplegia delivery as an etiology.
Unfortunately, Paparella and colleagues1 were not able to
detect an association between cTnI increase and the type
(P ¼ .26), temperature (P ¼ .17), or mode of delivery
(P ¼ .32) of the cardioplegic solution. Importantly, howev-
er, they do shine a bright light on the disappointing fact that
we have not yet achieved ‘‘optimal’’ myocardial preserva-
tion practice—especially during mitral valve surgery.
To date, cardiac surgeons have focused on driving down
myocardial oxygen and substrate use after the application of
the crossclamp. The Fullerton laboratory in Colorado2,3 has
identified an interleukin 1–nuclear factor k B–heat shock
protein 27 inflammatory pathway that is provoked by
crossclamp-induced ischemia and reperfusion. Cardiac sur-
geons should glory in the recognition that we already
deserve a favorable grade for protecting cardiomyocytes
during surgery. If we dream of truly aspiring to honors sta-
tus, however, perhaps we should add an anti-inflammatory
agent to our cardioplegic solution.
It would seem that a ‘‘risk’’ is avoidable only when you
haven’t taken it yet. Once cardiomyocytes are dead, and
the cTnI is detected, the dead ones become a handicap,
not a risk. The message of this important study1 therefore
is that to prevent our patients’ souls from crossing through
the pearly gates, we must not just target oxygen and sub-
strate imbalance in our myocardial preservation strategies
but also, perhaps, add a ‘‘pinch’’ of anti-inflammatory sauce
to our cardioplegic stew.References
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